tradingkey.logo
tradingkey.logo
Search

Denali Therapeutics Inc

DNLI
Add to Watchlist
23.310USD
-0.180-0.77%
Close 06/18, 16:00ETQuotes delayed by 15 min
3.64BMarket Cap
LossP/E TTM

Institutional Confidence

Currency: USD Updated: 2026-06-18
Previous score
10.00
Change
0
The current institutional shareholding score of Denali Therapeutics Inc is 10.00, ranking 1 out of 389 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 100.01%, representing a quarter-over-quarter decrease of 4.50%. The largest institutional shareholder is ETHSX, holding a total of 390.90K shares, representing 0.26% of shares outstanding, with 1.00% increase in holdings.

Institutional Shareholding

Shareholder Activity

Name
Shares Held
Chg %
Baillie Gifford & Co.
Star Investors
12.31M
+6.21%
BlackRock Institutional Trust Company, N.A.
10.41M
+2.80%
T. Rowe Price Investment Management, Inc.
7.25M
+28.65%
Biogen Inc
7.16M
-43.89%
Temasek Holdings Pte. Ltd.
7.01M
+30.94%
State Street Investment Management (US)
6.26M
+14.62%
Norges Bank Investment Management (NBIM)
5.12M
+29.70%
Fidelity Management & Research Company LLC
4.79M
-4.45%
1
2
KeyAI